Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christa Shilling

Pediatrics Bloomfield Hills, MI Medical Doctor

NPI 1306925623 CMS profile 826561

43097 Woodward Ave, Suite 201, Bloomfield Hills, MI 48302

Open in the dashboard

General payments

$3,234

167 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christa Shilling of Bloomfield Hills, MI is reported in the CMS Open Payments database as having received $3,234 across 167 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $533 22
2024 General $790 39
2023 General $508 30
2022 General $323 18
2021 General $519 29
2020 General $298 17
2019 General $264 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christa Shilling
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Christa Shilling were reported at $533. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Christa Shilling Pediatrics median Middle half National median
2019 $264 $86 $31–$183 $163
2020 $298 $49 $22–$110 $114
2021 $519 $68 $27–$158 $132
2022 $323 $77 $30–$173 $149
2023 $508 $88 $33–$190 $160
2024 $790 $94 $34–$206 $164
2025 $533 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. GlaxoSmithKline, LLC. $364 14 payments
  2. Tris Pharma Inc $361 20 payments
  3. Supernus Pharmaceuticals, Inc. $299 17 payments
  4. Corium, Inc. $286 22 payments
  5. Pfizer Inc. $283 14 payments
  6. Merck Sharp & Dohme Corporation $273 13 payments
  7. Ironshore Pharmaceuticals Inc. $247 12 payments
  8. Adlon Therapeutics L.P. $166 9 payments
  9. ALK-Abello, Inc $150 3 payments
  10. kaleo, Inc. $127 7 payments
  11. Other $679 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,234 167 payments
Products named General payments · program years 2019–2025
  1. Azstarys $286 22 payments
  2. GARDASIL 9 $230 11 payments
  3. BEXSERO $225 12 payments
  4. VAXELIS $212 10 payments
  5. JORNAY PM $212 10 payments
  6. QELBREE $191 11 payments
  7. ROTATEQ $190 9 payments
  8. Dyanavel XR $174 11 payments
  9. EUCRISA $174 9 payments
  10. VAXNEUVANCE $166 8 payments
  11. Other $2,487 122 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

167 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record